Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Anagin
AddedFeb 18, 2024
UpdatedJun 18, 2026
Anagin

Anagin

Anagin, based in Indianapolis, pioneers therapies for PTSD, TBI, depression, neuropathic pain, Alzheimer's, and Parkinson's.

HQ
Indianapolis, IN, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Anagin, founded in Indianapolis, is dedicated to developing first-in-class therapies for neuropsychiatric disorders such as Post Traumatic Stress Disorder (PTSD), Traumatic Brain Injury (TBI), depression, neuropathic pain, Alzheimer's disease, and Parkinson's disease. The company's core mission is to offer hope and improve the quality of life for millions of patients worldwide by addressing these debilitating conditions with innovative and targeted treatments.

Notable individuals associated with Anagin include experts in neuroscience and pharmacology who drive the company's research and development. The company has garnered attention for its pioneering approach and potential impact on mental health and neurodegenerative diseases. Anagin's achievements include significant advancements in preclinical studies, positioning it as a promising player in the biotech industry focused on neuropsychiatric therapeutics.

Anagin - Similar Companies

AgeneBio logo

AgeneBio

agenebio.com

Aptinyx logo

Aptinyx

aptinyx.com

Neuronascent logo

Neuronascent

neuronascent.com

Anapneo Therapeutics logo

Anapneo Therapeutics

Neuraly logo

Neuraly

neuralymed.com

Anvesana logo

Anvesana

Psy Therapeutics logo

Psy Therapeutics

psythx.com

SynAgile logo

SynAgile

Anagenex logo

Anagenex

anagenex.com

Ananda Scientific logo

Ananda Scientific

NeurAegis logo

NeurAegis

neuraegis.com

Anji Pharmaceuticals logo

Anji Pharmaceuticals

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

Anagin - Quick Facts

Who are Anagin's competitors?

Companies similar to Anagin include AgeneBio, Aptinyx, Neuronascent and Anapneo Therapeutics.

When was Anagin founded?

Anagin was founded in 2014.

Where is Anagin's headquarters located?

Anagin's headquarters is located in Indianapolis, IN, US.

How much has Anagin raised to-date?

As of Jan 1, 2017, Anagin has raised a total of $267.4k (USD).

How many employees does Anagin have?

Anagin has 7 employees as of Feb 5, 2024.

Anagin - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified